We are live on
!
Find out more
LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Est. Return
10.14%
This Fund
S&P 500
This Quarter
Est. Return
+7.65%
1 Year Est. Return
+10.14%
3 Year Est. Return
+35.77%
5 Year Est. Return
+141.26%
10 Year Est. Return
–
AUM
$939M
AUM Growth
+$86.2M
(+10%)
Cap. Flow
+$29.6M
Cap. Flow
% of AUM
3.15%
Top 10 Holdings %
Top 10 Hldgs %
46.18%
Holding
2,925
New
150
Increased
988
Reduced
857
Closed
215
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$5.37M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7M |
| 3 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$2.54M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$2.12M |
| 5 |
NVIDIA
NVDA
|
+$1.88M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$6.88M |
| 2 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$4.62M |
| 3 |
Oaktree Specialty Lending
OCSL
|
+$825K |
| 4 |
MGI
MoneyGram International, Inc. New
MGI
|
+$627K |
| 5 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$562K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.18% |
| 2 | Technology | 15.3% |
| 3 | Healthcare | 6.27% |
| 4 | Consumer Discretionary | 3.61% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Global X E-commerce ETF
EBIZ
$29.5M
| $74K | 0.01% |
4,000
| – | – |
|
577
M&T Bank
MTB
$36.2B
| $73.8K | 0.01% |
596
+101
| +20% | +$12.2K |
|
578
Aegon
AEG
$14.1B
| $73.4K | 0.01% |
14,471
+401
| +3% | +$1.84K |
|
579
Palantir
PLTR
$413B
| $73K | 0.01% |
4,763
+116
| +2% | +$1.32K |
|
580
TE Connectivity
TEL
$62.6B
| $72.9K | 0.01% |
520
-10
| -2% | -$1.26K |
|
581
Knowles
KN
$3.34B
| $72.9K | 0.01% |
4,034
+3,652
| +956% | +$61.4K |
|
582
CBRE Group
CBRE
$42.9B
| $72.7K | 0.01% |
901
+30
| +3% | +$2.25K |
|
583
Core Laboratories
CLB
$521M
| $72.6K | 0.01% |
3,122
| – | – |
|
584
Prudential Financial
PRU
$41.8B
| $72.4K | 0.01% |
821
-56
| -6% | -$4.68K |
|
|
PTRA
585
DELISTED
Proterra Inc. Common Stock
PTRA
| $72.4K | 0.01% |
60,310
+60,000
| +19,355% | +$73.7K |
|
586
Credicorp
BAP
$30.7B
| $72.3K | 0.01% |
490
+364
| +289% | +$50K |
|
|
ERF
587
DELISTED
Enerplus Corporation
ERF
| $72.3K | 0.01% |
4,994
+83
| +2% | +$1.21K |
|
588
Hormel Foods
HRL
$13.8B
| $72K | 0.01% |
1,791
+1,573
| +722% | +$63.1K |
|
589
iShares Core Dividend Growth ETF
DGRO
$43.6B
| $71.1K | 0.01% |
1,379
| – | – |
|
590
Cohen & Steers Infrastructure Fund
UTF
$3.04B
| $70.9K | 0.01% |
3,000
+1,000
| +50% | +$22.7K |
|
591
ETRACS MarketVector Business Development Companies Liquid Index ETN due Apr 26 2041
BDCZ
$16.7M
| $70.6K | 0.01% |
4,000
| – | – |
|
592
National Grid
NGG
$81.3B
| $70.6K | 0.01% |
1,113
+8
| +0.7% | +$525 |
|
593
Cognizant
CTSH
$26B
| $70.5K | 0.01% |
1,080
+275
| +34% | +$17K |
|
594
WPP
WPP
$5.94B
| $70.5K | 0.01% |
1,348
-17
| -1% | -$956 |
|
595
Entegris
ENTG
$23.2B
| $70.4K | 0.01% |
635
+36
| +6% | +$3.28K |
|
596
GSK
GSK
$106B
| $70.1K | 0.01% |
1,966
-749
| -28% | -$26.9K |
|
597
Devon Energy
DVN
$47.3B
| $69.9K | 0.01% |
1,446
-117
| -7% | -$5.88K |
|
598
Bio-Techne
TECH
$11.3B
| $69.6K | 0.01% |
853
+73
| +9% | +$5.87K |
|
599
Sixth Street Specialty
TSLX
$1.81B
| $69.5K | 0.01% |
3,718
-88
| -2% | -$1.6K |
|
600
The Mosaic Company
MOS
$7.33B
| $69.2K | 0.01% |
1,976
+358
| +22% | +$13.8K |
|
Similar funds
SBIA
CHP
MW
TAM
SIA
CIG
CCM
WCF
Lindbrook Capital's Q2 2023 Portfolio in Review
As of Q2 2023, Lindbrook Capital held 2,925 positions worth $939M, up 10% from $853M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Lindbrook Capital deployed $29.6M of net new capital in Q2 2023, opening 150 new positions and adding to 988 existing holdings. Its largest new stake was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $6.88M trimmed.
- Lindbrook Capital's largest Q2 2023 buy was UPAR Ultra Risk Parity ETF: 21,000 shares worth $291K.
- Lindbrook Capital added most to Vanguard Total International Stock ETF in Q2 2023, an estimated $5.37M increase.
- Lindbrook Capital's biggest Q2 2023 reduction was Vertex Pharmaceuticals, cutting an estimated $6.88M.
- Lindbrook Capital fully exited MoneyGram International, Inc. New in Q2 2023, selling an estimated $627K.
- Lindbrook Capital's ten largest holdings make up 46% of its $939M portfolio in Q2 2023.
- Lindbrook Capital opened 150 new positions and closed 215 in Q2 2023.
- Lindbrook Capital's portfolio value rose 10% quarter-over-quarter to $939M.
Based on Lindbrook Capital's 13F filing for Q2 2023, filed 31 Jul 2023.